Drugmaker Indivior Plc said on Thursday its full-year operating profit rose largely due to cost cuts even as it braces for the launch of cheaper copies of its blockbuster drug Suboxone after a long patent battle in U.S. courts.
![]()
By REUTERS from NYT Business https://nyti.ms/2Ia5bg8
By REUTERS from NYT Business https://nyti.ms/2Ia5bg8
Costs Cuts Help Indivior Post 2018 Profit Jump
![Costs Cuts Help Indivior Post 2018 Profit Jump]()
Reviewed by Unknown
on
February 14, 2019
Rating:
No comments: